Showing results (731-740 of 1,615) with videos related to
Sort By:
Pageof 162
Cancer Journal (Sudbury, Mass.)|April 9, 2008
A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)Philippe Chollet, Catherine Abrial, Xavier Durando, et al.Cancer Journal (Sudbury, Mass.)|October 18, 2016
Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A ReviewChristos E Kyriakopoulos, Glenn LiuCancer Journal (Sudbury, Mass.)|October 18, 2016
Immune Therapy for Prostate CancerOladapo Yeku, Susan F SlovinCancer Journal (Sudbury, Mass.)|June 10, 2008
Antibody engineering principles and applicationsLiNa Loo, Matthew K Robinson, Gregory P AdamsCancer Journal (Sudbury, Mass.)|June 10, 2008
Antibody-drug conjugates for cancer therapyPaul J Carter, Peter D SenterCancer Journal (Sudbury, Mass.)|June 10, 2008
Antibodies and hematologic malignanciesMitchell R SmithCancer Journal (Sudbury, Mass.)|July 24, 2019
Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical TrialsLaura M Yee, Lisa M McShane, Boris Freidlin, et al.Cancer Journal (Sudbury, Mass.)|January 24, 2017
Inhibitors of Cytotoxic T Lymphocyte Antigen 4 and Programmed Death 1/Programmed Death 1 Ligand for Metastatic Melanoma, Dual Versus Monotherapy-Summary of Advances and Future Directions for Studying These DrugsKimberly Loo, Adil I DaudCancer Journal (Sudbury, Mass.)|January 24, 2017
Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further InvestigationFreddy E Escorcia, Michael A Postow, Christopher A BarkerCancer Journal (Sudbury, Mass.)|January 24, 2017
Intratumoral Approaches for the Treatment of MelanomaPraveen K Bommareddy, Ann W Silk, Howard L KaufmanPageof 162